IP Verse

Use Of Akkermansia For Treating Metabolic Disorders

Patent No. EP3862010 (titled "Use Of Akkermansia For Treating Metabolic Disorders") was filed by Compagnie Gervais Danone on Nov 15, 2013. The application was issued on May 7, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SOCIT DES PRODUITS NESTLFeb 6, 2026D YOUNG
NESTLEFeb 6, 2026D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3862010

COMPAGNIE GERVAIS DANONE
Application Number
EP21154064A
Filing Date
Nov 15, 2013
Status
Granted And Under Opposition
Apr 4, 2025
Publication Date
May 7, 2025
External Links
Slate, Register , Google Patents